XML 77 R15.htm IDEA: XBRL DOCUMENT
v3.20.1

Equity Transactions and Stock Incentive Plans | 12 Months Ended
--- | ---
Dec. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Equity Transactions and Stock Incentive Plans | Note 9 – Equity Transactions and Stock Incentive Plans Overview of Stock Incentive Plans On August 27, 2015, the Board of Directors of the Company approved the Golden Entertainment, Inc. 2015 Incentive Award Plan (the “2015 Plan”), which was approved by the Company’s shareholders at the Company’s 2016 annual meeting. The 2015 Plan authorizes the issuance of stock options, restricted stock, restricted stock units, dividend equivalents, stock payment awards, stock appreciation rights, performance bonus awards and other incentive awards. The 2015 Plan authorizes the grant of awards to employees, non-employee directors and consultants of the Company and its subsidiaries. Options generally have a ten-year term. Except as provided in any employment agreement between the Company and the employee, if an employee is terminated (voluntarily or involuntarily), any unvested options as of the date of termination will be forfeited. The maximum number of shares of the Company’s common stock for which grants may be made under the 2015 Plan is 2.25 million shares, plus an annual increase on January 1st of each year during the ten-year term of the 2015 Plan equal to the lesser of 1.8 million shares, 4% of the total shares of the Company’s common stock outstanding (on an as-converted basis) and such smaller amount as may be determined by the Board of Directors in its sole discretion. The annual increase on January 1, 2019 was 1,119,924 shares. In addition, the maximum aggregate number of shares of common stock that may be subject to awards granted to any one participant during a calendar year is 2.0 million shares. As of December 31, 2019, a total of 1,280,000 shares of the Company’s common stock remained available for grants of awards under the 2015 Plan. Stock Options The following table summarizes the Company’s stock option activity:
|  |  | Weighted- |  |  |  |  |  |  |  |  |
|  |  |  |  |  | Average |  |  |  |  |  |  | Aggregate |
|  | Stock |  |  | Remaining |  |  | Weighted- |  |  | Intrinsic |
|  | Options |  |  | Term |  |  | Average |  |  | Value |
|  | Outstanding |  |  | (in years) |  |  | Exercise Price |  |  | (in thousands) |
Outstanding at January 1, 2019 |  |  | 3,424,755 |  |  |  | 7.4 |  |  | $ | 11.49 |  |  |  |  |
Granted |  |  | — |  |  |  |  |  |  | $ | — |  |  |  |  |
Exercised |  |  | (271,984 | ) |  |  |  |  |  | $ | 10.08 |  |  |  |  |
Cancelled |  |  | (26,250 | ) |  |  |  |  |  | $ | 11.69 |  |  |  |  |
Expired |  |  | — |  |  |  |  |  |  | $ | — |  |  |  |  |
Outstanding at December 31, 2019 |  |  | 3,126,521 |  |  |  | 6.1 |  |  | $ | 11.61 |  |  | $ | 24,991 |
Exercisable at December 31, 2019 |  |  | 2,728,721 |  |  |  | 5.9 |  |  | $ | 11.42 |  |  | $ | 22,496 |
The total intrinsic value of stock options exercised during the years ended December 31, 2019, 2018 and 2017 was $1.6 million, $16.1 million and $0.1 million, respectively. The weighted-average grant-date fair value of stock options granted during the year ended December 31, 2017 was $7.30 per share. No stock options were granted during the years ended December 31, 2019 and 2018. The total amount of cash received from stock options exercised during the year ended December 31, 2019 was $0.1 million. The Company issues new shares of common stock upon exercise of stock options. The Company uses the Black-Scholes option pricing model to estimate the fair value and compensation cost associated with employee incentive stock options, which requires the consideration of historical employee exercise behavior data and the use of a number of assumptions including volatility of the Company’s stock price, the weighted-average risk-free interest rate and the weighted-average expected life of the options. The Company’s determination of fair value of share-based option awards on the date of grant using the Black-Scholes option pricing model is affected by the following assumptions regarding complex and subjective variables. Any changes in these assumptions may materially affect the estimated fair value of the share-based award.
| • | Expected dividend yield — As the Company has not historically paid dividends, with the exception of the Special Dividend, the dividend rate variable used in the Black-Scholes model is zero.
| • | Risk-free interest rate — The risk-free interest rate assumption is based on the U.S. Treasury yield curve in effect at the time of grant and with maturities consistent with the expected term of options.
| • | Expected term — The expected term of employee stock options represents the weighted-average period that the stock options are expected to remain outstanding. It is based upon the Company’s experience as to the average historical term of option grants that were exercised, canceled or forfeited. Management believes historical data is reasonably representative of future exercise behavior.
| • | Expected volatility — The volatility assumption is based on the historical actual volatility of the Company’s stock. Management concluded there were no factors identified which were unusual and which would distort the volatility figure if used to estimate future volatility. Future volatility may be substantially less or greater than expected volatility.
RSUs and PSUs On March 14, 2018, the Compensation Committee of the Board of Directors of the Company approved a new long-term incentive structure for equity awards to be granted to the executive officers of the Company under the 2015 Plan. Under this new structure, commencing in the first quarter of 2018, the executive officers of the Company receive long-term equity awards in a combination of RSUs and PSUs. The number of PSUs that will be eligible to vest with respect to these PSU awards will be determined based on the Company’s attainment of performance goals set by the Compensation Committee. Following the two-year performance period, the number of “vesting eligible” PSUs will then be subject to one additional year of time-based vesting. Share-based compensation costs related to RSU and PSU awards are calculated based on the market price on the date of the grant. The Company periodically reviews the estimates of performance against the defined criteria to assess the expected payout of each outstanding PSU grant and adjusts the stock compensation expense accordingly. The following table summarizes the Company’s RSU activity:
|  | RSUs |
|  |  |  |  |  |  |  |  |  | Total |
|  |  |  |  |  | Weighted- |  |  | Fair Value |
|  |  |  |  |  | Average |  |  | of Shares |
|  |  |  |  |  | Grant Date |  |  | Vested |
|  | Shares |  |  | Fair Value |  |  | (in thousands) |
Outstanding at January 1, 2017 |  |  | 141,296 |  |  | $ | 12.57 |  |  |  |  |
Granted |  |  | — |  |  |  |  |  |  |  |  |
Vested |  |  | (111,660 | ) |  | $ | 12.57 |  |  | $ | 2,556 |
Cancelled |  |  | (29,636 | ) |  | $ | 12.57 |  |  |  |  |
Outstanding at December 31, 2017 |  |  | — |  |  |  |  |  |  |  |  |
Granted |  |  | 241,542 |  |  | $ | 29.09 |  |  |  |  |
Vested |  |  | — |  |  |  |  |  |  | $ | — |
Cancelled |  |  | (9,243 | ) |  | $ | 28.72 |  |  |  |  |
Outstanding at December 31, 2018 |  |  | 232,299 |  |  | $ | 29.10 |  |  |  |  |
Granted |  |  | 564,805 |  |  | $ | 13.88 |  |  |  |  |
Vested |  |  | (103,224 | ) |  | $ | 29.61 |  |  | $ | 1,596 |
Cancelled |  |  | (32,622 | ) |  | $ | 20.77 |  |  |  |  |
Outstanding at December 31, 2019 |  |  | 661,258 |  |  | $ | 16.44 |  |  |  |  |
The following table summarizes the Company’s PSU activity:
|  | PSUs |
|  |  |  |  |  |  |  |  |  | Total |
|  |  |  |  |  | Weighted- |  |  | Fair Value |
|  |  |  |  |  | Average |  |  | of Shares |
|  |  |  |  |  | Grant Date |  |  | Vested |
|  | Shares(1) |  |  | Fair Value |  |  | (in thousands) |
Outstanding at January 1, 2017 |  |  | — |  |  |  |  |  |  |  |  |
Granted |  |  | 62,791 |  |  | $ | 27.87 |  |  |  |  |
Vested |  |  | — |  |  |  |  |  |  | $ | — |
Cancelled |  |  | — |  |  |  |  |  |  |  |  |
Outstanding at December 31, 2017 |  |  | 62,791 |  |  | $ | 27.87 |  |  |  |  |
Granted |  |  | 108,957 |  |  | $ | 28.72 |  |  |  |  |
Vested |  |  | — |  |  |  |  |  |  | $ | — |
Cancelled |  |  | — |  |  |  |  |  |  |  |  |
Outstanding at December 31, 2018 |  |  | 171,748 |  |  | $ | 28.41 |  |  |  |  |
Granted |  |  | 204,580 |  |  | $ | 14.13 |  |  |  |  |
Vested |  |  | — |  |  |  |  |  |  | $ | — |
Cancelled |  |  | — |  |  |  |  |  |  |  |  |
Outstanding at December 31, 2019 |  |  | 376,328 |  |  | $ | 20.65 |  |  |  |  |
(1) | The number of shares listed for PSUs granted during 2017 represents the actual number of PSUs granted to each recipient eligible to vest if the Company meets its performance goals for the applicable period. The number of shares listed for PSUs granted after 2017 represents the “target” number of PSUs granted to each recipient eligible to vest if the Company meets its “target” performance goals for the applicable period. The actual number of PSUs eligible to vest with respect to PSUs granted after 2017 will vary depending on whether or not the Company meets or exceeds the applicable threshold, target or maximum performance goals for the PSUs, with 200% of the “target” number of PSUs eligible to vest at “maximum” performance levels.
Share-Based Compensation The following table summarizes share-based compensation costs by award type:
|  | Year Ended December 31, |
(In thousands) |  | 2019 |  |  | 2018 |  |  | 2017 |
Stock options |  | $ | 4,850 |  |  | $ | 5,191 |  |  | $ | 5,135 |
RSUs |  |  | 4,284 |  |  |  | 3,383 |  |  |  | 3,554 |
PSUs |  |  | 911 |  |  |  | 1,067 |  |  |  | 65 |
Total share-based compensation costs |  | $ | 10,045 |  |  | $ | 9,641 |  |  | $ | 8,754 |
As of December 31, 2019, the Company’s unrecognized share-based compensation expenses related to stock options, RSUs and PSUs was approximately $2.1 million, $6.3 million and $2.8 million, respectively, which are expected to be recognized over a weighted-average period of 1.0 year, 2.4 years, and 1.9 years, respectively. Equity Transactions In January 2018, the Company completed an underwritten public offering pursuant to its universal shelf registration statement, in which certain of the Company’s shareholders resold an aggregate of 6.5 million shares of the Company’s common stock, and the Company sold 975,000 newly issued shares of its common stock pursuant to the exercise in full of the underwriters’ over-allotment option to purchase additional shares. The Company’s net proceeds from the offering were $25.6 million after deducting underwriting discounts and offering expenses. On November 7, 2018, the Board of Directors authorized the repurchase of up to $25.0 million shares of common stock, subject to available liquidity, general market and economic conditions, alternate uses for the capital and other factors. The Company uses the par value method of accounting for its stock repurchases. As a result of the stock repurchases, the Company reduces common stock and records charges to accumulated deficit. During the year ended December 31, 2018, the Company repurchased approximately 1.2 million shares of its $0.01 par value common stock in open market transactions at an average price of $16.06 per share, resulting in a charge to accumulated deficit of approximately $19.6 million. On March 12, 2019, the Board of Directors authorized the repurchase of up to $25.0 million worth of additional shares of common stock, subject to available liquidity, general market and economic conditions, alternate uses for the capital and other factors, which replaces the November 2018 share repurchase program. Share repurchases may be made from time to time in open market transactions, block trades or in private transactions in accordance with applicable securities laws and regulations and other legal requirements, including compliance with the Company’s finance agreements. There is no minimum number of shares that the Company is required to repurchase and the repurchase program may be suspended or discontinued at any time without prior notice. No shares were repurchased during the year ended December 31, 2019.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration